Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study

NCT06758648 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT06758648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06758648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational Study
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Recruiting
Start date
June 25, 2020
Completion date
November 1, 2025
Enrollment
63 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial dysfunction, fabry disease, microvasculature